We've made it easier for you to connect! Fill out your NEW profile.

Enhertu Improves Survival in People With HER2-Low MBC

moderators
moderators Posts: 8,963

A New Standard of Care? Enhertu Improves Survival in People With Metastatic HER2-Low Breast Cancer
June 6, 2022

Compared with doctors' choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer. Read more...

Welcome!

It looks like you're new here. Sign in or register to get started.